Clinical Trial Update: A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized study evaluating a taxane and bevacizumab with or without capecitabine as first-line therapy for metastatic breast cancer has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Taxane (unspecified) (taxane)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED